Injectable Contraceptive Linked to Elevated Breast Cancer Risk

Share this article:
Injectable Contraceptive Linked to Elevated Breast Cancer Risk
Injectable Contraceptive Linked to Elevated Breast Cancer Risk

(HealthDay News) – Recent use of the injectable contraceptive depo-medroxyprogesterone acetate (DMPA) for 12 months or longer may approximately double the risk of breast cancer in young women.

To investigate the association between DMPA use and breast cancer risk, Christopher I. Li, MD, PhD, from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a population-based study among 1,028 women aged 20–44 years. Structured, in-person questionnaires were completed to obtain information on DMPA use and other relevant covariates.

The researchers observed a 2.2-fold increased risk of invasive breast cancer with recent DMPA use for >12 months. There was little variation in the risk by tumor stage, size, hormone receptor expression, or histological subtype.

"Although breast cancer is rare among young women and the elevated risk of breast cancer associated with DMPA appears to dissipate after discontinuation of use, our findings emphasize the importance of identifying the potential risks associated with specific forms of contraceptives given the number of available alternatives," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs